HomeIONS • NASDAQ
add
Ionis Pharmaceuticals Inc
Previous close
$64.04
Day range
$63.07 - $64.61
Year range
$23.95 - $64.72
Market cap
10.07B USD
Avg Volume
3.01M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 452.05M | 100.69% |
Operating expense | 90.62M | 39.18% |
Net income | 123.55M | 286.45% |
Net profit margin | 27.33 | 192.90% |
Earnings per share | 0.85 | 452.98% |
EBITDA | 142.68M | 326.46% |
Effective tax rate | -0.02% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.29B | 9.95% |
Total assets | 2.99B | 10.92% |
Total liabilities | 2.35B | -3.05% |
Total equity | 631.72M | — |
Shares outstanding | 159.39M | — |
Price to book | 16.13 | — |
Return on assets | 12.06% | — |
Return on capital | 13.82% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 123.55M | 286.45% |
Cash from operations | 151.34M | 226.24% |
Cash from investing | -120.07M | -292.26% |
Cash from financing | 1.25M | -51.23% |
Net change in cash | 33.11M | 160.32% |
Free cash flow | 98.52M | 197.53% |
About
Ionis Pharmaceuticals, Inc. is a biotechnology that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015. Wikipedia
Founded
1989
Headquarters
Website
Employees
1,069
